Abstract |
New pyrimidine nucleoside analogs (18 compounds) were synthesized and their growth-inhibiting and differentiation-inducing activities on human myeloid leukemia HL-60 cells were examined. Some of the analogs were found to induce nitroblue tetrazolium (NBT) reducing activity in the HL-60 cells. The inducing activities of these compounds were compared at their concentrations for 50% inhibition of cell growth. TI-79 (3-benzyl-5-methyl-3-(beta-D-ribofuranosyl)pyrido[2,3-d] pyrimidine- 2,4(1H,3H)-dione) was a very effective inducer of NBT-reduction and of differentiation of the cells into mature granulocytes. The induction of NBT-reducing activity by TI-79 was inhibited by high concentrations of the natural nucleoside, adenosine. Other differentiation inducers, such as retinoic acid, 1 alpha,25-dihydroxyvitamin D-3 and staurosporin markedly enhanced the induction of differentiation of HL-60 cells by TI-79. Nucleoside analogs such as TI-79 should be useful for differentiation therapy of some types of myelogenous leukemia.
|
Authors | M Makishima, Y Honma, M Hozumi, K Sampi, M Hattori, I Ishikawa, H Ogura, N Kawahara, T Kanaiwa, K Motoyoshi |
Journal | Biochimica et biophysica acta
(Biochim Biophys Acta)
Vol. 1094
Issue 1
Pg. 1-7
(Aug 13 1991)
ISSN: 0006-3002 [Print] Netherlands |
PMID | 1883847
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Antineoplastic Agents
- Pyrimidine Nucleosides
- Ribonucleosides
- TI 79
- Nitroblue Tetrazolium
- Adenosine
|
Topics |
- Adenosine
(pharmacology)
- Antineoplastic Agents
(pharmacology)
- Cell Differentiation
(drug effects)
- Cell Division
(drug effects)
- Cell Line
- Granulocytes
(drug effects)
- Humans
- Leukemia, Myeloid, Acute
(drug therapy, pathology)
- Nitroblue Tetrazolium
(chemistry)
- Oxidation-Reduction
- Pyrimidine Nucleosides
(chemical synthesis, pharmacology)
- Ribonucleosides
(pharmacology)
- Tumor Cells, Cultured
|